Pre-treatment predictors of cardiac dose exposure in left-sided breast cancer radiotherapy patients after breast conserving surgery
Author:
Xu Lixia12, Wang Hui12, Wang Jiahao3, Ren Yao12, Zhang Lidan12, Deng Wenfan12, Li Xiadong12
Affiliation:
1. Medical Imaging and Translational Medicine Laboratory, Hangzhou Cancer Center , Hangzhou , China 2. Department of Radiotherapy , Affiliated Hangzhou Cancer Hospital, Zhejiang University School of Medicine , Hangzhou , China 3. Department of Radiotherapy , Affiliated Women’s Hospital, Zhejiang University School of Medicine , Hangzhou , China
Abstract
Abstract
Objectives
This study aimed to identify high-risk factors for high cardiac radiation exposure, based on anatomical measurements taken from planning CT images of patients with left-sided breast cancer who underwent breast-conserving surgery and received radiotherapy.
Methods
We retrospectively analyzed 45 patients with left-sided breast cancer who underwent whole-breast radiotherapy, either under free breathing (27/45) or deep inspiratory breath-holding (DIBH) (18/45), after breast-conserving surgery. Six anatomical parameters were measured from planning CT images, including treatment planning target volume (PTV), cardiopulmonary volume ratio (CVR), maximum cardiac margin distance, the relative distance between inferior boundaries of heart and PTV (DBIB(H2P)), axial cardiac contact distance, and para-sagittal cardiac contact distance (CCDps). Multiple linear regression analysis was performed using SPSS software to explore the correlation between the six parameters, body mass index (BMI), and the mean heart dose (MHD). Receiver operating characteristic (ROC) analysis was performed to evaluate the predictive power of the selected predictor of cardiac dose exposure.
Results
Significant correlations were observed between the MHD of patients and the CVR, DBIB(H2P), and CCDps parameters. Among them, the CVR was the most important predictor of cardiac dose exposure, with an area under the curve of 0.915 and a cut-off value of 0.17.
Conclusions
The study results indicated that CVR, DBIB(H2P), and CCDps are the primary parameters associated with the risk of cardiac dose exposure, with CVR being the most significant predictor. Further prospective studies are required to determine whether these parameters can be used to identify patients who would benefit from the DIBH technique.
Funder
Hangzhou Health Science and Technology Project, China The Natural Science Foundation of Zhejiang Province, China
Publisher
Walter de Gruyter GmbH
Reference24 articles.
1. Sung, H, Ferlay, J, Siegel, RL, Laversanne, M, Soerjomataram, I, Jemal, A, et al.. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209–49. https://doi.org/10.3322/caac.21660. 2. Shah, C, Bauer-Nilsen, K, McNulty, RH, Vicini, F. Novel radiation therapy approaches for breast cancer treatment. Semin Oncol 2020;47:209–16. https://doi.org/10.1053/j.seminoncol.2020.05.003. 3. Vaidya, JS, Bulsara, M, Wenz, F. Ischemic heart disease after breast cancer radiotherapy. N Engl J Med 2013;368:2526–7. https://doi.org/10.1056/NEJMc1304601. 4. Darby, SC, Ewertz, M, McGale, P, Bennet, AM, Blom-Goldman, U, Bronnum, D, et al.. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med 2013;368:987–98. https://doi.org/10.1056/nejmoa1209825. 5. Giordano, SH, Kuo, YF, Freeman, JL, Buchholz, TA, Hortobagyi, GN, Goodwin, JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005;97:419–24. https://doi.org/10.1093/jnci/dji067.
|
|